The Olimel Portfolio provides a comprehensive range of olive oil-based parenteral nutrition formulations designed to meet the specific metabolic needs of critically ill and surgical patients. Its triple-chamber system delivers balanced proteins, glucose, and lipids to support healing and manage disease-related malnutrition. Multiple formulations with varying protein content and electrolyte options allow clinicians to tailor therapy to diverse patient requirements. Olimel N12, the highest protein option, is suited for patients experiencing significant catabolic stress. With its evidence-based lipid profile and flexible configuration, the Olimel Portfolio supports safe, effective, and individualized parenteral nutrition management across clinical settings.